Doctor profile · Federal record
Dr. Grace Ayandibu, M.D, M.S, LPC
Procedural Dermatology Physician (CMS: Dermatology) · Mental Health Counselor · Student in an Organized Health Care Education/Training Program · Wichita Falls, TX
- NPI 1023395928
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 8 yrs in practice
- Licensed in 2 states
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2637 Plaza Pkwy
Wichita Falls, TX 763083889
(940) 239-9160
Credentials & registration
- NPI registered
- November 2011 — 15 yrs on file
- Profile last updated
- April 10, 2023
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207NS0135X — NUCC code
- State licenses (2)
- Texas #T9346 · Illinois #178007242
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023395928. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,524
Distinct HCPCS
10
Medicare allowed
$193,837
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,520 | 260 | $6 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 440 | 440 | $107 | |
17000 |
Destruction of precancer skin growth, 1 growth | 357 | 296 | $54 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 205 | 203 | $158 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 180 | 149 | $86 | |
17110 |
Destruction of skin growth, 1-14 growths | 172 | 148 | $107 | |
11102 |
Biopsy of related skin growth, first growth | 171 | 156 | $88 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 110 | 22 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 92 | 72 | $54 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 66 | 48 | $118 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 185. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$364
Transactions
18
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $106.67 | |
| Lilly USA, LLC | 3 | $59.13 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $46.04 | |
| ABBVIE INC. | 2 | $37.88 | |
| Biofrontera Inc. | 3 | $37.35 | |
| Verrica Pharmaceuticals Inc. | 1 | $17.65 | |
| Organogenesis Inc. | 1 | $16.22 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $14.56 | |
| Arcutis Biotherapeutics, Inc. | 1 | $14.23 | |
| Galderma Laboratories, L.P. | 1 | $14.15 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
604
Patients
397
Total drug cost
$18,286
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 153 | 94 | $3,243 |
| Clobetasol Propionate | Generic | 80 | 62 | $3,425 |
| Mupirocin | Generic | 56 | 50 | $474 |
| Mometasone Furoate | Generic | 53 | 48 | $1,317 |
| Triamcinolone Acetonide | Generic | 50 | 42 | $827 |
| Doxycycline Hyclate | Generic | 38 | 33 | $1,497 |
| Hydrocortisone | Generic | 36 | 32 | $634 |
| Fluorouracil | Generic | 29 | 23 | $2,992 |
| Hydroxyzine Hcl | Generic | 19 | 0 | $198 |
| Ammonium Lactate | Generic | 17 | 0 | $456 |
Hospital affiliations
Frequently asked questions
What is Dr. Grace Ayandibu's medical specialty?
Dr. Grace Ayandibu practices Procedural Dermatology Physician in Wichita Falls, TX.
Where does Dr. Grace Ayandibu practice?
Dr. Grace Ayandibu practices at 2637 Plaza Pkwy, Wichita Falls, TX 763083889. Office phone: 9402399160.
What is Dr. Grace Ayandibu's NPI?
Dr. Grace Ayandibu's National Provider Identifier (NPI) is 1023395928, issued by NPPES.
Does Dr. Grace Ayandibu accept Medicare assignment?
Yes. Dr. Grace Ayandibu accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Grace Ayandibu commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); New patient office or other outpatient visit (HCPCS 99203); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.